Stock Information
Crinetics Pharmaceuticals Inc (CRNX)
Ticker Symbol: CRNX
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $3,464.70 mil
Piotroski score: 5
PE Ratio: N/A
EPS (TTM): -5.1331
Revenue (TTM): $0.17 M
Dividend Yield: N/A%
ROE: -43.96%
Latest News
-
Crinetics Pharmaceuticals, Inc. (CRNX) Presents at Endocrine Society's Annual Meeting (ENDO 2026) - Slideshow
Mon, Jun 15, 2026 4:30 PM
-
HC Wainwright & Co. Reiterates Buy on Crinetics Pharmaceuticals, Maintains $81 Price Target
Mon, Jun 15, 2026 6:02 AM
-
Reported Sunday, Crinetics Presents Up To Two-Year PATHFNDR Open-Label Extension Data At ENDO 2026 Confirming PALSONIFY Maintains Stable IGF-1 Levels And Acromegaly Symptom Control
Mon, Jun 15, 2026 2:55 AM
-
Reported Sunday, Crinetics Presents Phase 2 Data For Atumelnant In CAH Showing 67% Mean Reduction In Androstenedione Levels With 88% Of Participants Achieving Physiologic Glucocorticoid Dose At Week 12
Mon, Jun 15, 2026 2:54 AM
Key Financials
Financial data not available
